File(s) under permanent embargo
AMR policy dialogue: driving innovative solutions for antimicrobial discovery
report
posted on 2023-06-10, 04:27 authored by Alexander GhionisAlexander Ghionis, Tom Barker, Chris DowsonAntimicrobial resistance (AMR) is a global strategic priority and sits within the UK Government’s National Risk Register. By 2050, AMR is predicted to cause 10 million deaths, more than cancer. In 2019 alone, there were an estimated 4.95 million deaths associated with bacterial AMR. Although global pharmaceutical research and development (R&D) spend continues to increase year on year, research into antimicrobial drug discovery is not currently an attractive commercial investment. This has had two major consequences: an ongoing decline of human capital for R&D in this field, and a decline over the longer term in availability of therapeutically effective antibiotics and other antimicrobial agents. Concerted and coordinated efforts are needed to translate high-level policy commitments into strategic actions for long-term funding and support for the R&D of new antimicrobials.
History
Publication status
- Published
File Version
- Published version
Publisher
University of WarwickPages
7.0Place of publication
University of Warwick, UKDepartment affiliated with
- SPRU - Science Policy Research Unit Publications
Institution
University of WarwickFull text available
- No
Legacy Posted Date
2022-08-10First Compliant Deposit (FCD) Date
2022-08-10Usage metrics
Categories
No categories selectedKeywords
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC